Literature DB >> 23546444

Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.

Bo Remenyi1, Jonathan Carapetis, Rosemary Wyber, Kathryn Taubert, Bongani M Mayosi.   

Abstract

In the 21(st) century, rheumatic fever (RF) and rheumatic heart disease (RHD) are neglected diseases of marginalized communities. Globally, RHD remains the most-common cardiovascular disease in young people aged <25 years. Although RF and RHD have been almost eradicated in areas with established economies, migration from low-income to high-income settings might be responsible for a new burden of RHD in high-income countries. The World Heart Federation (WHF) and its Working Group on RF and RHD unites global experts, combines their experience and enthusiasm, and provides a platform for RHD control. This paper is a declaration of the WHF institutional strategic goal--a 25% reduction in premature deaths from RF and RHD among individuals aged <25 years by the year 2025. The position statement affirms WHF commitments to five key strategic targets: comprehensive register-based control programmes, global access to benzathine penicillin G, identification and development of public figures as 'RHD champions', expansion of RHD training hubs, and support for vaccine development. In this paper, we also review existing barriers to RF and RHD control and identify the actions required to change the trajectory of control for these diseases. This approach provides the foundation for governments, civil society, patient advocates, clinicians, researchers, and funding agencies to develop partnerships and unify global efforts to control RF and RHD. The WHF plans to expand this position statement to an operational plan that will be founded on science, research, and quantifiable progress indicators to impact positively on the millions of people who are affected by RHD and its long-term sequelae.

Entities:  

Mesh:

Year:  2013        PMID: 23546444     DOI: 10.1038/nrcardio.2013.34

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  67 in total

Review 1.  Rheumatic heart disease.

Authors:  Eloi Marijon; Mariana Mirabel; David S Celermajer; Xavier Jouven
Journal:  Lancet       Date:  2012-03-10       Impact factor: 79.321

2.  Rheumatic fever: neglected again.

Authors:  David A Watkins; Liesl J Zuhlke; Mark E Engel; Bongani M Mayosi
Journal:  Science       Date:  2009-04-03       Impact factor: 47.728

Review 3.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

4.  Prophylaxis of recurrent rheumatic fever. Therapeutic-continuous oral penicillin vs monthly injections.

Authors:  A R Feinstein; M Spagnuolo; S Jonas; H Kloth; E Tursky; M Levitt
Journal:  JAMA       Date:  1968-10-14       Impact factor: 56.272

5.  Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic.

Authors:  Rachel H Webb; Nigel J Wilson; Diana R Lennon; Elizabeth M Wilson; Ross W Nicholson; Tom L Gentles; Clare P O'Donnell; John W Stirling; Irene Zeng; Adrian A Trenholme
Journal:  Cardiol Young       Date:  2011-03-31       Impact factor: 1.093

6.  Pregnancy in women with heart disease in sub-Saharan Africa.

Authors:  Maboury Diao; Adama Kane; Mouhamadou Bamba Ndiaye; Alassane Mbaye; Malick Bodian; Mouhamadoul Mounir Dia; Moustapha Sarr; Abdoul Kane; Jean-Jacques Monsuez; Serigne Abdou Ba
Journal:  Arch Cardiovasc Dis       Date:  2011-06-14       Impact factor: 2.340

7.  Rheumatic Fever Programme in Samoa.

Authors:  Satupaitea Viali; Puleiala Saena; Vailogoua Futi
Journal:  N Z Med J       Date:  2011-02-11

8.  Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association.

Authors: 
Journal:  JAMA       Date:  1992-10-21       Impact factor: 56.272

9.  The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease.

Authors:  Michael D Seckeler; Tracey R Hoke
Journal:  Clin Epidemiol       Date:  2011-02-22       Impact factor: 4.790

10.  Cardiac disease in pregnancy.

Authors:  T Nqayana; J Moodley; D P Naidoo
Journal:  Cardiovasc J Afr       Date:  2008 May-Jun       Impact factor: 1.167

View more
  79 in total

1.  Decreased Prevalence of Rheumatic Heart Disease Confirmed Among HIV-positive Youth.

Authors:  Ian W Hovis; Judith Namuyonga; Grace P Kisitu; Emma Ndagire; Emmy Okello; Chris T Longenecker; Amy Sanyahumbi; Craig A Sable; Daniel J Penny; Peter Lwabi; Adeodata R Kekitiinwa; Andrea Beaton
Journal:  Pediatr Infect Dis J       Date:  2019-04       Impact factor: 2.129

2.  Rheumatic Heart Disease Treatment Cascade in Uganda.

Authors:  Chris T Longenecker; Stephen R Morris; Twalib O Aliku; Andrea Beaton; Marco A Costa; Moses R Kamya; Cissy Kityo; Peter Lwabi; Grace Mirembe; Dorah Nampijja; Joselyn Rwebembera; Craig Sable; Robert A Salata; Amy Scheel; Daniel I Simon; Isaac Ssinabulya; Emmy Okello
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-11

3.  The control of rheumatic fever and rheumatic heart disease: a call to raise the awareness.

Authors:  Sirageldin M Kheir; Sulafa Khalid M Ali
Journal:  Sudan J Paediatr       Date:  2014

Review 4.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

Review 5.  Rheumatic heart disease: current status of diagnosis and therapy.

Authors:  Ferande Peters; Ganesan Karthikeyan; Jessica Abrams; Lorrein Muhwava; Liesl Zühlke
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

Review 6.  A glimpse of hope: cardiac surgery in low- and middle-income countries (LMICs).

Authors:  Peter Zilla; R Morton Bolman; Percy Boateng; Karen Sliwa
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

7.  Rheumatic Fever: a neglected and underdiagnosed disease. New perspective on diagnosis and prevention.

Authors:  Carlos Eduardo de Barros Branco; Roney Orismar Sampaio; Mario Maia Bracco; Samira Saady Morhy; Marcelo Luiz Campos Vieira; Luiza Guilherme; Luiz Vicente Rizzo; Flavio Tarasoutch
Journal:  Arq Bras Cardiol       Date:  2016-11       Impact factor: 2.000

8.  Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica.

Authors:  Sheron Boswell Thompson; Cerese Hepburn Brown; Ann Marie Edwards; Jascinth L M Lindo
Journal:  Pathog Glob Health       Date:  2014-08-11       Impact factor: 2.894

9.  Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study).

Authors:  Liesl Zühlke; Mark E Engel; Ganesan Karthikeyan; Sumathy Rangarajan; Pam Mackie; Blanche Cupido; Katya Mauff; Shofiqul Islam; Alexia Joachim; Rezeen Daniels; Veronica Francis; Stephen Ogendo; Bernard Gitura; Charles Mondo; Emmy Okello; Peter Lwabi; Mohammed M Al-Kebsi; Christopher Hugo-Hamman; Sahar S Sheta; Abraham Haileamlak; Wandimu Daniel; Dejuma Y Goshu; Senbeta G Abdissa; Araya G Desta; Bekele A Shasho; Dufera M Begna; Ahmed ElSayed; Ahmed S Ibrahim; John Musuku; Fidelia Bode-Thomas; Basil N Okeahialam; Olukemi Ige; Christopher Sutton; Rajeev Misra; Azza Abul Fadl; Neil Kennedy; Albertino Damasceno; Mahmoud Sani; Okechukwu S Ogah; Taiwo Olunuga; Huda H M Elhassan; Ana Olga Mocumbi; Abiodun M Adeoye; Phindile Mntla; Dike Ojji; Joseph Mucumbitsi; Koon Teo; Salim Yusuf; Bongani M Mayosi
Journal:  Eur Heart J       Date:  2014-11-25       Impact factor: 29.983

10.  Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever.

Authors:  Rosemary Wyber; Ben J Boyd; Samantha Colquhoun; Bart J Currie; Mark Engel; Joseph Kado; Ganesan Karthikeyan; Mark Sullivan; Anita Saxena; Meru Sheel; Andrew Steer; Joseph Mucumbitsi; Liesl Zühlke; Jonathan Carapetis
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.